Biodistribution and endocytosis of ICAM-1-targeting antibodies versus nanocarriers in the gastrointestinal tract in mice
Viraj Mane,1 Silvia Muro1, 21Institute for Bioscience and Biotechnology Research, 2Fischell Department of Bioengineering, University of Maryland, College Park, MD, USAAbstract: Drug delivery to the gastrointestinal (GI) tract is key for improving treatment of GI maladies, developing oral vaccines, a...
Guardado en:
Autores principales: | Mane V, Muro S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4b57a4be86ea428d9090a6ef26f5b56b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Endocytosis and Organelle Targeting of Nanomedicines in Cancer Therapy
por: Wang X, et al.
Publicado: (2020) -
Targeting of Mammalian Glycans Enhances Phage Predation in the Gastrointestinal Tract
por: Sabrina I. Green, et al.
Publicado: (2021) -
An anti-human ICAM-1 antibody inhibits rhinovirus-induced exacerbations of lung inflammation.
por: Stephanie Traub, et al.
Publicado: (2013) -
Translational Clinical Strategies for the Prevention of Gastrointestinal Tract Graft Versus Host Disease
por: Aditya Rayasam, et al.
Publicado: (2021) -
Are the solutions to radiotherapy side effects on the gastrointestinal tract right at our doorstep?
por: Christoph Berliner
Publicado: (2021)